Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
Does the levels of GM1 antibody (IGG or IGM- tested by the enzyme immunoassay (EIA) method) reduce after treatment for CIDP with IVIG?
should this be monitored over time ?
Related Questions
How do you identify patients with false positive AcHR antibodies?
When do you use rozanolixizumab for Musk MG?
When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?
Beyond fatigability, what distinctive features of diplopia characterize myasthenia gravis?
What do you consider when there is incidentally found patchy peripheral nerve enlargement on imaging with otherwise unremarkable clinical and electrophysiological findings?
How do you use muscle MRI in the diagnosis and management of muscular dystrophies?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
How are you counseling your patients with ALS taking sodium phenylbutyrate and taurursodiol on continuing treatment in light of the negative phase 3 trial results?
How do you counsel patients with dermatomyositis on sun protection?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?